A young student’s research explored existing medicines for Alzheimer’s disease protection. He identified two drugs, nintedanib and pirfenidone, showing protective effects in cell models. This drug repurposing approach offers a faster, less expensive research starting point. Wang’s work highlights targeting APOE4 and brain blood vessel cell changes. His findings suggest further investigation into TGFβ pathway drugs is warranted.
In an exciting collaboration, Sadhguru and Graphic India are creating an animated feature film that…
FedEx will invest $150 million to build a new air cargo hub in Delhi. This…
China is the biggest buyer of Iranian crude - around 90% of Iran’s oil exports…